II.4 Is ovarian cyst formation related to tamoxifen use?
- 31 August 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34, S21-S22
- https://doi.org/10.1016/s0959-8049(98)00093-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowthBritish Journal of Cancer, 1994
- Risk of endometrial cancer after tamoxifen treatment of breast cancerThe Lancet, 1994
- The Royal Marsden Hospital pilot tamoxifen chemoprevention trialBreast Cancer Research and Treatment, 1994
- Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (breast cancer adjuvant chemo-hormone therapy cooperative group) trialEuropean Journal Of Cancer, 1992
- Oral contraceptive type and functional ovarian cystsAmerican Journal of Obstetrics and Gynecology, 1992
- Incidence of New Primary Cancers After Adjuvant Tamoxifen Therapy and Radiotherapy for Early Breast CancerJNCI Journal of the National Cancer Institute, 1991
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989